Industry: Health Care – Biotechnology: Pharmaceutical Preparations
Stock Symbol: BBOT – NASDAQ
Animal Usage: Animal Testing
BridgeBio Oncology Therapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
Supporting Evidence:
The company confirms in the following report that they exploit animals for product testing.
BridgeBio Oncology Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of small-molecule therapeutics targeting renin-angiotensin system and phosphoinositide 3-kinase malignancies. The company was founded in 2016 is headquartered in South San Francisco, California.
Company Website: https://www.bbotx.com